RESVERAC
Pharmaceutical and veterinary preparations for treatment of cellular damage due to oxidating agents, DNA damage due to estrogen initiated cancers, general decay of vascular, skeletal and neuro-muscular system, and vitamin D3 deficiency; medicines for treatment of cellular damage due to oxidating agents, DNA damage due to estrogen initiated cancers, general decay of vascular, skeletal and neuro-muscular system, and vitamin D3 deficiency for human and animal use; dietetic substances, namely, an...
Cancelled · December 15, 2015 · 79182066 ·